Parathyroidism: Hypo, Hyper....what is normal, really?

SPONSORED BY: DiaSorin, DiaSorin
  • Division Head, Bone and Mineral Metabolism, Henry Ford Health System

      Dr. Rao is the Section Head, Bone & Mineral Metabolism & Director of Bone & Mineral Research Laboratory, Henry Ford Hospital, Detroit, MI, USA, a position he has held continuously since 1995. It is the best bone histomorphometry lab in the state, and one of the best in the country. Under his direction, the lab has been conducting both basic and clinical research, and published extensively on the pathogenesis of bone fragility, age related bone loss, mechanism of atypical fractures, role of vitamin D in parathyroid adenoma size and disease expression, and on parathyroid tumorigenesis.

      Dr. Rao has more than 100 peer reviewed papers, 100 symposium proceedings, abstracts, and letters to the editor, and 10 book chapters. He is a founding member of the Indian Society of Bone & Mineral Research, which he helped launch in 1997.

      Dr. Rao has received a number of awards including the Willard O. Thomson travelling scholar award from the American college of Physicians in 1986, the Boy Frame award from the American Society for Bone and Mineral Research in 1999. He is a fellow of the American College of Physicians (FACP) and of the American Association of Clinical Endocrinologists (FACE)


    Hyper and Hypoparathyroid disease states are often latent with a multiplicity of manifestations ranging from asymptomatic state to obvious symptoms and complications such as fatigue, depression, kidney stones, bone fractures and intracranial calcifications.  Both conditions are associated with significant morbidity related to cardiac and vascular calcifications, hypertension, and seizure disorders.  As Dr. Rao picks up the normality enigma, the altered parathyroid state and its importance will be addressed diagnostically as it applies to the choices made in the course of clinical management.

    Show Resources
    Loading Comments...